| 注册
首页|期刊导航|中国妇幼健康研究|无创产前检测筛查胎儿性染色体变异的价值

无创产前检测筛查胎儿性染色体变异的价值

侯帅 刘学晴 李彩云 阳敏 刘颖慧 张昊晴

中国妇幼健康研究2026,Vol.37Issue(9):53-59,7.
✕
中国妇幼健康研究2026,Vol.37Issue(9):53-59,7.DOI:10.3969/j.issn.1673-5293.2026.09.008

无创产前检测筛查胎儿性染色体变异的价值

The value of noninvasive prenatal testing in screening for fetal sex chromosome variation

侯帅 1刘学晴 2李彩云 1阳敏 1刘颖慧 1张昊晴1

作者信息

  • 1. 郴州市第一人民医院产前诊断中心,湖南 郴州 423001
  • 2. 南华大学附属郴州医院产前诊断中心,湖南 衡阳 421001
  • 折叠

摘要

Abstract

Objective To explore the clinical screening efficacy and application value of noninvasive prenatal testing(NIPT)for fetal sex chromosome variations.Methods A retrospective analysis was conducted on the NIPT results of 38 034 singleton pregnancies at the prenatal diagnosis center of the first people's hospital of Chenzhou from January 2021 to December 2024.For those with positive fetal sex chromosome variations indicated by NIPT,peripheral blood karyotype analysis,amniotic fluid karyotype analysis,and copy number variation sequencing(CNV-seq)were performed for verification.The positive rate of screening in each group was compared using χ2 test,and independent influencing factors of fetal sex chromosome aneuploidy abnormalities(SCAs)were analyzed using multivariate Logistic regression.Results 154 cases of chromosomal aneuploidy(SCAs)were detected by NIPT,with a detection rate of 0.41%.Compared with the<35 years old group,the detection rate of fetal SCAs in the≥35 years old group was higher,and the difference was statistically significant(χ2=12.86,P<0.05);after adjusting for confounding factors,being≥35 years old for the pregnant woman was an independent risk factor for fetal SCAs(OR=1.77,95%CI:1.30-2.41,P<0.05);the overall positive predictive value(PPV)of NIPT for SCAs was 50.00%,and the PPV of the four types of SCAs karyotypes was as follows:47,XXY(83.33%),47,XXX(66.67%),47,XYY(55.56%),45,X(33.33%).Among the 59 cases with confirmed chromosomal variations(including 2 cases inconsistent with the NIPT indication),the induction rate was 52.54%(31/59),and all 55 NIPT false positive cases delivered full-term babies.No abnormalities were found in the newborn follow-up.Conclusion NIPT has reliable clinical application value for screening fetal SCAs.Combined with amniotic fluid karyotype and CNV-seq,it can clearly diagnose chromosomal variations,providing a basis for clinical genetic counseling and pregnancy management.

关键词

无创产前检测/胎儿/性染色体非整倍体/核型分析/拷贝数变异测序/妊娠结局

Key words

noninvasive prenatal testing/fetus/sex chromosome aneuploidy/karyotype analysis/copy number variations sequencing/pregnancy outcome

分类

医药卫生

引用本文复制引用

侯帅,刘学晴,李彩云,阳敏,刘颖慧,张昊晴..无创产前检测筛查胎儿性染色体变异的价值[J].中国妇幼健康研究,2026,37(9):53-59,7.

基金项目

郴州市技术研发中心(202029) (202029)

中国妇幼健康研究

1673-5293

访问量0
|
下载量0
段落导航相关论文